Search results for “Chimpanzee adenovirus” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 165 patents, we discovered top 26 key players by total patent application. GlaxoSmithKline Biologicals SA, Glaxo Group Ltd., MSD Italia Srl are dominant in this area. They take 61.82% of the total patent filing.
GlaxoSmithKline Biologicals SA
Belgium
Patent: 64
Glaxo Group Ltd.
Hounslow, United Kingdom
Patent: 20
MSD Italia Srl
Lazio, Italy
Patent: 18
Oxford University Innovation Ltd.
United Kingdom
Patent: 13
Gritstone bio, Inc.
California, United States
Patent: 7
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 6
Yidao Biotechnology (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 4
Akamis Bio Ltd.
United Kingdom
Patent: 3
IP2IPO Innovations Ltd.
United Kingdom
Patent: 3
Jiaxing Anyu Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 78 patents applied in the last 5 years. We discover 24 most active companies in this area. The fast-growing GlaxoSmithKline Biologicals SA, Ludwig Institute for Cancer Research Ltd., Glaxosmithkline Intellectual Property Development Ltd. take 69.23% of patent filing during this period.
GlaxoSmithKline Biologicals SA
Belgium
Patent: 39
Ludwig Institute for Cancer Research Ltd.
New York, United States
Patent: 9
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 6
Yidao Biotechnology (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 4
Institute of Microbiology
Bulgaria
Patent: 3
Jiaxing Anyu Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 3
Department of Health & Human Services
Australia
Patent: 2
Albert B. Sabin Vaccine Institute, Inc.
District of Columbia, United States
Patent: 2
Beijing Jiaotong University
Beijing Shi, China
Patent: 2
GENEMATRIX, Inc.
Gyeonggi-do, South Korea
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 78 patents in last 5 years, we discover 16 new entrants. Ludwig Institute for Cancer Research Ltd., Glaxosmithkline Intellectual Property Development Ltd., Yidao Biotechnology (Suzhou) Co., Ltd. are the most active new entrants in this area.
Ludwig Institute for Cancer Research Ltd.
New York, United States
Patent: 9
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 6
Yidao Biotechnology (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 4
Jiaxing Anyu Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 3
Beijing Jiaotong University
Beijing Shi, China
Patent: 2
GENEMATRIX, Inc.
Gyeonggi-do, South Korea
Patent: 2
Tsinghua University
Beijing Shi, China
Patent: 2
Chengdu Bo Pet Biotechnology Co., Ltd.
Sichuan Sheng, China
Patent: 1
BASF AB
Sweden
Patent: 1
Beijing Luzhu Biopharmaceutical Co., Ltd.
Beijing Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 41 patents, we discovered top 4 universities and scientific research institutions by total patent application. Institute of Microbiology, Tsinghua University, Beijing Jiaotong University are dominant in this area. They take 51.22% of the total patent filing.
Institute of Microbiology
Bulgaria
Patent: 4
Tsinghua University
Beijing Shi, China
Patent: 2
Beijing Jiaotong University
Beijing Shi, China
Patent: 2
McMaster University
Ontario, Canada
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: